Scientists have developed a three-in-one blood test that has the potential to transform the treatment of advanced prostate cancer through the use of precision drugs designed to target mutations in the BRCA genes.
Report that suggested CRISPR is too dangerous to use as a drug was wrong, say biotech companies
The NIH has announced that it will be devoting $1billion a year specifically to funding proposals from early and mid-career investigators
Direct-to-consumer (DTC) genetic test results could begin to encourage individuals to move closer to maintaining a healthy diet and exercise regime
Mapping every cell of the human body is a top priority for scientists funded by a $3 billion investment by Facebook founder and his wife